InvestorsHub Logo

ExtremelyBullishZig

11/03/23 7:53 AM

#437945 RE: Hazel2323 #437943

So does every company with ongoing trials regarding their respective drugs. It isn't difficult to get data from a CRO and then pay another company to go through it.

nidan7500

11/03/23 9:08 AM

#437951 RE: Hazel2323 #437943

Hazel12323

Anavex is extremely slow. However, the company has amassed a huge amount of detailed data related to the Blarcamesine trial in order to show regulatory agencies how the drug works. Anavex is more prepared than any other company when talking to regulatory agencies.



Agree w/your comment about AVXL speed but (we must ask .Why is that true).
IMO, there are (at least) two good reasons for the time required to prepare and to present our CNS (This, is a football) story.

1. AI is (can be) complex as it requires a certain amount of background in order to appreciate and to understand what is being presented/said since both the logic of how the pieces fit together and the integration of the learning translated for conventional thinking and AI-SCI- knowledge. (AI requires training to even sit in the room and understand what is being said.) Getting everyone on the same page (avoid audience blank stares) is a non-trivial (step 1) requirement.

2. Once AVXL start to explain the logic and structure of the CNS functions conversion (using A.I. Speak). AVXL will then need to walk everyone through the science of S1R Bio-sci in context (CNS functionals) in order to relate the results to the basic "HOW COME ???" proof of concept w/ links to
trial results.

So, IMO, this is NOT your Father's Oldsmobile. We first have to educate the FDA so they can understand and agree that the proof of our claims (safe and effective) are valid. Getting everyone's head around the evidence / proof of , "Safe and effective". will take additional time.
...Simple use of A.I. Speak will not work, the audience must understand what is being said....requires multiple sessions w/ frequent repeats as everyone gets up their own-curve.

BTW, IMO, silence is a key indicator of this process being implemented...some times FDA will not even understand how to phrase the question(s) they want to ask. B/C They do not know , what they do not know.